Your browser doesn't support javascript.
loading
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.
Wallington-Beddoe, Craig T; Bennett, Melissa K; Vandyke, Kate; Davies, Lorena; Zebol, Julia R; Moretti, Paul A B; Pitman, Melissa R; Hewett, Duncan R; Zannettino, Andrew C W; Pitson, Stuart M.
Afiliación
  • Wallington-Beddoe CT; Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
  • Bennett MK; SA Pathology, Adelaide, Australia.
  • Vandyke K; School of Medicine, University of Adelaide, Australia.
  • Davies L; Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
  • Zebol JR; SA Pathology, Adelaide, Australia.
  • Moretti PAB; School of Medicine, University of Adelaide, Australia.
  • Pitman MR; SA Pathology, Adelaide, Australia.
  • Hewett DR; School of Medicine, University of Adelaide, Australia.
  • Zannettino ACW; South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Pitson SM; Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
Oncotarget ; 8(27): 43602-43616, 2017 Jul 04.
Article en En | MEDLINE | ID: mdl-28467788
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fosfotransferasas (Aceptor de Grupo Alcohol) / Estrés del Retículo Endoplásmico / Bortezomib / Mieloma Múltiple / Antineoplásicos Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fosfotransferasas (Aceptor de Grupo Alcohol) / Estrés del Retículo Endoplásmico / Bortezomib / Mieloma Múltiple / Antineoplásicos Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article